60 Degrees Pharmaceuticals, Inc. Share Price & Technical Analysis
SXTP · $1.48 (-0.67%)
Healthcare / Biotechnology
$1.48
-0.67%
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications;…
Price chart
Seasonality
May has 1 positive and 2 negative years (last 4 years shown)
-6% return in May, 11% avg return in past 3 year May month.
26% return in 2026, -132% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 100% | -16% | -40% | -11% | -6% | – | – | – | – | – | – | – | 26% |
| 25 | -44% | -49% | -1% | 49% | -2% | -7% | -45% | 6% | 5% | -7% | -22% | -52% | -169% |
| 24 | -73% | -4% | -3% | -15% | 23% | -14% | -41% | -23% | -10% | -37% | 34% | 19% | -144% |
| 23 | – | – | – | – | – | – | -40% | -34% | -48% | -30% | -2% | 70% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.00M
P/E ratio
—
52W high
$14.68
52W low
$1.29
Volume
49,620
Beta
2.70
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is 60 Degrees Pharmaceuticals, Inc. share price today?
- 60 Degrees Pharmaceuticals, Inc. (SXTP) last traded around $1.48 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SXTP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SXTP. Download the app for real-time alerts.
- How can I analyze 60 Degrees Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.